[{"target":11,"price":3.860,"returns":177,"ticker":"INO","note":"Avg. Price Target Opinion: Inovio Pharmaceuticals (INO) likely to achieve $10.75 in 52-week period - Voice Of Analysts","to_char":"04/23/2019","q_eps":null,"a_eps":-1.050,"report":"analyst","q_pe":null,"a_pe":null,"divyield":null},{"target":18,"price":6.670,"returns":174,"ticker":"AKBA","note":"Price Target Recommendation: Akebia Therapeutics (AKBA) to knock at $18.3 in coming one year period - Voice Of Analysts","to_char":"04/22/2019","q_eps":null,"a_eps":-2.470,"report":"analyst","q_pe":null,"a_pe":null,"divyield":null},{"target":18,"price":7.490,"returns":144,"ticker":"CHAP","note":"Price Target Summary: Chaparral Energy (CHAP) likely to touch $18.38 in 52-week period - Voice Of Analysts","to_char":"04/23/2019","q_eps":null,"a_eps":0.730,"report":"analyst","q_pe":null,"a_pe":null,"divyield":null},{"target":3,"price":1.180,"returns":112,"ticker":"CTHR","note":"Price Target Summary: Charles & Colvard, Ltd. (CTHR) likely to touch $2.5 in 52-week period - Voice Of Analysts","to_char":"04/24/2019","q_eps":null,"a_eps":-0.080,"report":"analyst","q_pe":null,"a_pe":null,"divyield":null},{"target":17,"price":8.390,"returns":98,"ticker":"CEPU","note":"Price Target Recommendation: Central Puerto S.A. (CEPU) to knock at $16.68 in coming one year period - Voice Of Analysts","to_char":"04/23/2019","q_eps":null,"a_eps":4.640,"report":"analyst","q_pe":null,"a_pe":null,"divyield":null}]
